Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes.

Rodriguez GM, Bobbala D, Serrano D, Mayhue M, Champagne A, Saucier C, Steimle V, Kufer TA, Menendez A, Ramanathan S, Ilangumaran S.

Oncoimmunology. 2016 Mar 28;5(6):e1151593. doi: 10.1080/2162402X.2016.1151593. eCollection 2016 Jun.

2.

Listeria monocytogenes and the Inflammasome: From Cytosolic Bacteriolysis to Tumor Immunotherapy.

Theisen E, Sauer JD.

Curr Top Microbiol Immunol. 2016;397:133-60. doi: 10.1007/978-3-319-41171-2_7.

PMID:
27460808
3.

NLRC5, a promising new entry in tumor immunology.

Chelbi ST, Guarda G.

J Immunother Cancer. 2016 Jul 19;4:39. doi: 10.1186/s40425-016-0143-z. eCollection 2016.

4.

NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Yoshihama S, Roszik J, Downs I, Meissner TB, Vijayan S, Chapuy B, Sidiq T, Shipp MA, Lizee GA, Kobayashi KS.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9.

PMID:
27162338
5.

A distant trophoblast-specific enhancer controls HLA-G expression at the maternal-fetal interface.

Ferreira LM, Meissner TB, Mikkelsen TS, Mallard W, O'Donnell CW, Tilburgs T, Gomes HA, Camahort R, Sherwood RI, Gifford DK, Rinn JL, Cowan CA, Strominger JL.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):5364-9. doi: 10.1073/pnas.1602886113. Epub 2016 Apr 13.

PMID:
27078102
6.

Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.

Gurung P, Kanneganti TD.

Cell Mol Life Sci. 2016 Aug;73(16):3035-51. doi: 10.1007/s00018-016-2212-3. Epub 2016 Mar 31. Review.

PMID:
27032699
7.

T Cell Priming by Activated Nlrc5-Deficient Dendritic Cells Is Unaffected despite Partially Reduced MHC Class I Levels.

Rota G, Ludigs K, Siegert S, Tardivel A, Morgado L, Reith W, De Gassart A, Guarda G.

J Immunol. 2016 Apr 1;196(7):2939-46. doi: 10.4049/jimmunol.1502084. Epub 2016 Mar 4.

8.

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions.

Ludigs K, Jandus C, Utzschneider DT, Staehli F, Bessoles S, Dang AT, Rota G, Castro W, Zehn D, Vivier E, Held W, Romero P, Guarda G.

Nat Commun. 2016 Feb 10;7:10554. doi: 10.1038/ncomms10554.

9.

Genetic Signature of Resistance to White Band Disease in the Caribbean Staghorn Coral Acropora cervicornis.

Libro S, Vollmer SV.

PLoS One. 2016 Jan 19;11(1):e0146636. doi: 10.1371/journal.pone.0146636. eCollection 2016.

10.

Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.

Coutermarsh-Ott S, Eden K, Allen IC.

J Gen Virol. 2016 Apr;97(4):825-38. doi: 10.1099/jgv.0.000401. Epub 2016 Jan 13. Review.

PMID:
26763980
11.

NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.

Li X, Guo F, Liu Y, Chen HJ, Wen F, Zou B, Li D, Qin Q, Liu X, Shen Y, Wang Y.

Oncol Lett. 2015 Sep;10(3):1533-1540. Epub 2015 Jul 8.

12.

Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.

Guo X, Liu T, Shi H, Wang J, Ji P, Wang H, Hou Y, Tan RX, Li E.

J Virol. 2015 Aug;89(15):7636-45. doi: 10.1128/JVI.00349-15. Epub 2015 May 13.

13.

NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.

Ludigs K, Seguín-Estévez Q, Lemeille S, Ferrero I, Rota G, Chelbi S, Mattmann C, MacDonald HR, Reith W, Guarda G.

PLoS Genet. 2015 Mar 26;11(3):e1005088. doi: 10.1371/journal.pgen.1005088. eCollection 2015 Mar.

14.

Holding the inflammatory system in check: NLRs keep it cool.

Jha S, Pan-Yun Ting J.

F1000Prime Rep. 2015 Feb 3;7:15. doi: 10.12703/P7-15. eCollection 2015. Review.

15.

Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Kaakoush NO, Deshpande NP, Man SM, Burgos-Portugal JA, Khattak FA, Raftery MJ, Wilkins MR, Mitchell HM.

Infect Immun. 2015 Feb;83(2):832-45. doi: 10.1128/IAI.03012-14. Epub 2014 Dec 8.

16.

Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells.

Camargo R, Faria LO, Kloss A, Favali CB, Kuckelkorn U, Kloetzel PM, de Sá CM, Lima BD.

PLoS One. 2014 Apr 21;9(4):e95977. doi: 10.1371/journal.pone.0095977. eCollection 2014.

17.

Transcriptional and posttranscriptional regulations of the HLA-G gene.

Castelli EC, Veiga-Castelli LC, Yaghi L, Moreau P, Donadi EA.

J Immunol Res. 2014;2014:734068. doi: 10.1155/2014/734068. Epub 2014 Mar 13. Review.

18.

NLRC5/CITA: a novel regulator of class I major histocompatibility complex genes.

Kobayashi KS.

J immunodefic Disord. 2012;1(1). pii: 1000e102. No abstract available.

19.

Prognostic value of microRNA expression in operable non-small cell lung cancer patients.

Skrzypski M, Czapiewski P, Goryca K, Jassem E, Wyrwicz L, Pawłowski R, Rzyman W, Biernat W, Jassem J.

Br J Cancer. 2014 Feb 18;110(4):991-1000. doi: 10.1038/bjc.2013.786. Epub 2014 Jan 21.

20.

Licensing Adaptive Immunity by NOD-Like Receptors.

Liu D, Rhebergen AM, Eisenbarth SC.

Front Immunol. 2013 Dec 27;4:486. doi: 10.3389/fimmu.2013.00486. Review.

Items per page

Supplemental Content

Write to the Help Desk